Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2010
08/25/2010EP2094265B1 Pyrroloy[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
08/25/2010EP2069302B1 Substituted pyridylmethyl bicyclocarboxyamide compounds
08/25/2010EP1987033B1 Diazabicycloalkane derivatives and their medical use
08/25/2010EP1908830B1 Non-human gene-disrupted animal having adam11 gene disruption
08/25/2010EP1807434B1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
08/25/2010EP1755647B1 Treatment of amyotrophic lateral sclerosis
08/25/2010EP1641792B1 Pyrrolodihydroisoquinolines as pde10 inhibitors
08/25/2010EP1637531B1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
08/25/2010EP1620082B9 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
08/25/2010EP1594436B1 Mutated neublastin
08/25/2010EP1551834B1 Substituted quinazolinone compounds
08/25/2010EP1481679B1 Antidepressant
08/25/2010EP1469882B1 Treatment of nervous system diseases with goat serum
08/25/2010EP1404367B1 Use of polyclonal anti-hiv goat serum as a therapeutic agent
08/25/2010EP1385857B1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010EP1324755B1 Pharmaceutical solutions of modafinil compounds
08/25/2010EP1263722B1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
08/25/2010EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
08/25/2010EP1181047B9 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
08/25/2010EP1133294B1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
08/25/2010CN201558345U Health care sachet
08/25/2010CN1969641B Sugar-free soybean milk for infants
08/25/2010CN1969640B Liquid milk capable of supplying ketone
08/25/2010CN1903315B Use of active parts of fibrous root of Radix ophiopogonis
08/25/2010CN1785281B Quality control method of spirit quieting oral liquid preparation
08/25/2010CN1709340B Medicinal composition for nourishing heart-disney, invigorating brain and tranquilizing mind, and its preparing method and use
08/25/2010CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
08/25/2010CN101815700A Derivatives of 4-(2-amino-1 -hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
08/25/2010CN101815530A Therapeutic antibody purification method and method of use
08/25/2010CN101815517A Nerve cell death inhibitor
08/25/2010CN101815515A Intranasal pharmaceutical compositions comprising succinic acid
08/25/2010CN101815512A cyclopropyl aryl amide derivatives and uses thereof
08/25/2010CN101812065A Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
08/25/2010CN101812056A A novel pyridine derivative substituted by alkyl acting as an reuptaking inhibitor for the monoamine neurotransmitter.
08/25/2010CN101812008A IDO inhibitor containing pyrrole-2-aryl structure and preparation method thereof
08/25/2010CN101810843A Medicament for treating nerve system diseases such as cerebrovascular accident, spinal cord injury and senile dementia
08/25/2010CN101810842A Method for preparing puerariae decoction particles
08/25/2010CN101810834A Chinese medicinal composition for treating paralysis and preparation method thereof
08/25/2010CN101810824A Chinese medicament for curing post-stroke hand-shoulder syndrome
08/25/2010CN101810815A Antismoking liqueur
08/25/2010CN101810814A Medicament for curing cerebral palsy, hyperkinetic syndrome and dementia and preparation method thereof
08/25/2010CN101810808A Chinese medicinal composition for treating tremor and preparation method thereof
08/25/2010CN101810789A Chinese medicinal preparation for treating epilepsy
08/25/2010CN101810783A Chinese medicinal preparation for curing cerebral hemorrhage
08/25/2010CN101810767A Chinese medicinal composition for tonifying qi and yin
08/25/2010CN101810740A Chinese medicinal preparation for treating encephalatrophy
08/25/2010CN101810728A Chinese medicinal preparation for curing headache
08/25/2010CN101810725A Formula of orally-taken Chinese medicament for treating migraine
08/25/2010CN101810702A Medicated wine and preparation method thereof
08/25/2010CN101810701A Medicinal tea for preventing cerebral apoplexy
08/25/2010CN101810691A Traditional Chinese medicine composition with effects of tranquillization and pain relief for livestock and poultry and preparation method thereof
08/25/2010CN101810689A Formula of batryticated silkworm processed by gall bladder
08/25/2010CN101810683A Chinese medicinal compound preparation for curing migraine and preparation process thereof
08/25/2010CN101810679A Polyunsaturated fatty acid soft capsule and preparation method thereof
08/25/2010CN101810659A Total saponins of salvia chinensis benth, and medical application and preparation method thereof
08/25/2010CN101810658A Method for removing residual pesticide from ginseng
08/25/2010CN101810656A Siberian ginseng extract and medicine combination thereof
08/25/2010CN101810647A Method for supercritical CO2 extraction of total flavonoids of athyrium multidentatum ching
08/25/2010CN101810644A Production method of ant essential oil and ant oil soft capsule
08/25/2010CN101810632A Purpose of 4-cyan-beta-D-glucoside for curing tristimania
08/25/2010CN101810614A Stable pyritinol hydrochloride composition for injection and preparation and preparation method thereof
08/25/2010CN101810606A Application of 2-(6-hydroxyl-2',3'-dimethoxyphenyl)-6-hydroxyl-7-methoxy benzofuran for preparing monoamine oxidase inhibitor
08/25/2010CN101810586A L-dopa methyl ester sustained-release microsphere composite and preparation method thereof
08/25/2010CN101810547A Fast dissolving orally consumable films
08/25/2010CN101810525A Multifunctional shape-protecting health-care medicinal pillow for infant
08/25/2010CN101474022B External-use Chinese medicine refreshment pillow for treating coma patient with brain trauma
08/25/2010CN101264304B Chinese medicine capsule for treating intractable aypnia
08/25/2010CN101044908B High nutrition product developed from vertebra bone of freshwater eel
08/25/2010CN101041626B Tetrafluorobenzyl derivatives and pharmaceutical composition containing same
08/24/2010USRE41571 drug delivery at least two-day additional dosing interval; allows for reduced plasma concentrations over a prolonged time period while still providing effective pain management; transdermal delivery system maximizes the dosage interval; FDA Orange book listed patent
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781476 Serotonin and melatonergic ligands such as 10-(4-Methylpiperazin-1-ylmethyl)-5-thia-4b-aza-indeno[2,1-a]indene-5,5-dioxide, used for the treatment of psychological disorders, side effect reduction of antipsychotic drugs, neurodegenerative disorders, chemotherapy-induced vomiting and eating disorders
08/24/2010US7781463 Enzyme inhibitors
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010US7781450 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
08/24/2010US7781440 Neurodegenerative diseases caused by GSK3 such as Alzheimer's disease
08/24/2010US7781432 analgesic. especially acute, chronic and/or neuropathic pain; epilepsy and other CNS-related disorders as well as for neuroprotection or cardioprotection; 9-benzyl-8-(cyclopentylamine)-6-(4-nitrobenzyl-mercaptopurine
08/24/2010US7781429 solubilizing a nonsteroidal antiinflammatory drug (NSAID) such as diclofenac by combining with at least two of camphor, menthol and thymol
08/24/2010US7781427 cyclization of a 1,4-benzodiazepine with cyclopentene. in a diels-alders reaction to give a decahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline, then resolving to form diastereomeric salts and dimer impurities; neuroleptic and dietetic agents
08/24/2010US7781188 Nucleotide and protein sequences of Nogo genes and methods based thereon
08/24/2010CA2632585C Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound
08/24/2010CA2593618C Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing them
08/24/2010CA2582049C Bilayer tablet comprising telmisartan and amlodipine
08/24/2010CA2570805C 2-(1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence
08/24/2010CA2551182C Novel kappa receptor selective opioid peptides
08/24/2010CA2524377C Thiadiazine derivatives and use thereof as positive ampa receptor modulators
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2467857C Piperidine-based mch antagonists for treatment of obesity and cns disorders
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/24/2010CA2414583C Neuroprotective 7-beta-hydroxysteroids
08/24/2010CA2362757C Effervescent pharmaceutical formulation containing metamizole
08/24/2010CA2334858C Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression
08/24/2010CA2322716C Use of follistatin to modulate gdf-8 and bmp-11
08/24/2010CA2274985C Synthetic antisense oligodeoxynucleotides targeted to human acetylcholinesterase
08/24/2010CA2213560C Pharmaceutical compositions for controlled release of soluble receptors
08/19/2010WO2010093910A1 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
1 ... 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 ... 1833